The Canada nootropics supplement market was valued at $86.3 million in 2022, and is projected to reach $156.8 million by 2032, growing at a CAGR of 6.4% from 2023 to 2032.
The U.S. nootropics supplement market was valued at $657.2 million in 2022, and is projected to reach $1010.4 million by 2032, growing at a CAGR of 4.7% from 2023 to 2032.